Rita Sanghvi Mehta

Title(s)Health Sciences Professor, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5153
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, Socioeconomic Status, and Insurance Type. Cancers (Basel). 2023 Nov 26; 15(23). Ubbaonu CD, Chang J, Ziogas A, Mehta RS, Kansal KJ, Zell JA. PMID: 38067290; PMCID: PMC10705726.
      View in: PubMed   Mentions:
    2. Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226. Pharmacogenomics. 2023 08; 24(12):665-673. Rutherford DV, Medley S, Henderson NC, Gersch CL, Vandenberg TA, Albain KS, Dakhil SR, Tirumali NR, Gralow JR, Hortobagyi GN, Pusztai L, Mehta RS, Hayes DF, Kidwell KM, Henry NL, Barlow WE, Rae JM, Hertz DL. PMID: 37615099; PMCID: PMC10565537.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226). Biomarkers. 2023 May; 28(3):313-322. Bergqvist M, Nordmark A, Williams A, Paoletti C, Barlow W, Cobain EF, Mehta RS, Gralow JR, Hortobagyi GN, Albain KS, Pusztai L, Sharma P, Godwin AK, Thompson AM, Hayes DF, Rae JM. PMID: 36647745; PMCID: PMC10681159.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    4. Deep Learning-based Automatic Diagnosis of Breast Cancer on MRI Using Mask R-CNN for Detection Followed by ResNet50 for Classification. Acad Radiol. 2023 09; 30 Suppl 2:S161-S171. Zhang Y, Liu YL, Nie K, Zhou J, Chen Z, Chen JH, Wang X, Kim B, Parajuli R, Mehta RS, Wang M, Su MY. PMID: 36631349; PMCID: PMC10515321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Diagnosis of Breast Cancer Using Radiomics Models Built Based on Dynamic Contrast Enhanced MRI Combined With Mammography. Front Oncol. 2021; 11:774248. Zhao YF, Chen Z, Zhang Y, Zhou J, Chen JH, Lee KE, Combs FJ, Parajuli R, Mehta RS, Wang M, Su MY. PMID: 34869020; PMCID: PMC8637829.
      View in: PubMed   Mentions: 3  
    6. BI-RADS Reading of Non-Mass Lesions on DCE-MRI and Differential Diagnosis Performed by Radiomics and Deep Learning. Front Oncol. 2021; 11:728224. Zhou J, Liu YL, Zhang Y, Chen JH, Combs FJ, Parajuli R, Mehta RS, Liu H, Chen Z, Zhao Y, Pan Z, Wang M, Yu R, Su MY. PMID: 34790569; PMCID: PMC8591227.
      View in: PubMed   Mentions: 4  
    7. Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial. Clin Cancer Res. 2021 11 15; 27(22):6115-6123. Paoletti C, Barlow WE, Cobain EF, Bergqvist M, Mehta RS, Gralow JR, Hortobagyi GN, Albain KS, Pusztai L, Sharma P, Godwin AK, Thompson AM, Hayes DF, Rae JM. PMID: 34521624; PMCID: PMC8595696.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    8. Development of U-Net Breast Density Segmentation Method for Fat-Sat MR Images Using Transfer Learning Based on Non-Fat-Sat Model. J Digit Imaging. 2021 08; 34(4):877-887. Zhang Y, Chan S, Chen JH, Chang KT, Lin CY, Pan HB, Lin WC, Kwong T, Parajuli R, Mehta RS, Chien SH, Su MY. PMID: 34244879; PMCID: PMC8455741.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Asymmetry in the frequency and proportion of arm truncation in three sympatric California Octopus species. Zoology (Jena). 2021 08; 147:125940. Voss KM, Mehta RS. PMID: 34198204.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    10. Breast cancer differential diagnosis using diffuse optical spectroscopic imaging and regression with z-score normalized data. J Biomed Opt. 2021 02; 26(2). Cochran JM, Leproux A, Busch DR, O'Sullivan TD, Yang W, Mehta RS, Police AM, Tromberg BJ, Yodh AG. PMID: 33624457; PMCID: PMC7901858.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Automatic Detection and Segmentation of Breast Cancer on MRI Using Mask R-CNN Trained on Non-Fat-Sat Images and Tested on Fat-Sat Images. Acad Radiol. 2022 01; 29 Suppl 1:S135-S144. Zhang Y, Chan S, Park VY, Chang KT, Mehta S, Kim MJ, Combs FJ, Chang P, Chow D, Parajuli R, Mehta RS, Lin CY, Chien SH, Chen JH, Su MY. PMID: 33317911; PMCID: PMC8192591.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    12. Prediction of breast cancer molecular subtypes on DCE-MRI using convolutional neural network with transfer learning between two centers. Eur Radiol. 2021 Apr; 31(4):2559-2567. Zhang Y, Chen JH, Lin Y, Chan S, Zhou J, Chow D, Chang P, Kwong T, Yeh DC, Wang X, Parajuli R, Mehta RS, Wang M, Su MY. PMID: 33001309; PMCID: PMC8547260.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    13. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens. Breast Cancer Res. 2020 03 13; 22(1):29. Tank A, Peterson HM, Pera V, Tabassum S, Leproux A, O'Sullivan T, Jones E, Cabral H, Ko N, Mehta RS, Tromberg BJ, Roblyer D. PMID: 32169100; PMCID: PMC7071774.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    14. Effects of Diet and Intraspecific Scaling on the Viscera of Muraenid Fishes. Zoology (Jena). 2020 04; 139:125752. Gartner SM, Mehta RS. PMID: 32086144.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    15. Somatic BRCA2 Mutation-Positive Concurrent Accessory Male Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC): Excellent Efficacy of Palbociclib, Fulvestrant and Leuprolide in Platinum-Exposed and Endocrine-Refractory BC Associated with Cyclin D1 and FGFR1 Amplification and of Carboplatin, Paclitaxel and Radiation in NSCLC. Case Rep Oncol. 2019 May-Aug; 12(2):494-499. Cheng Y, Li N, Eapen A, Parajuli R, Mehta R. PMID: 31320873; PMCID: PMC6616081.
      View in: PubMed   Mentions: 2  
    16. Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer. N Engl J Med. 2019 03 28; 380(13):1226-1234. Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Linden HH, Livingston RB, Hortobagyi GN. PMID: 30917258; PMCID: PMC6885383.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    17. Benign Metastasizing Leiomyoma to the Lung and Spine: A Case Report and Literature Review. Case Rep Oncol. 2019 Jan-Apr; 12(1):218-223. Barber E, Eapen A, Mehta R, Lin E, Lane K, Cheng Y, Parajuli R. PMID: 31011319; PMCID: PMC6465748.
      View in: PubMed   Mentions: 9  
    18. Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment. J Biomed Opt. 2018 10; 24(2):1-11. Cochran JM, Busch DR, Leproux A, Zhang Z, O'Sullivan TD, Cerussi AE, Carpenter PM, Mehta RS, Roblyer D, Yang W, Paulsen KD, Pogue B, Jiang S, Kaufman PA, Chung SH, Schnall M, Snyder BS, Hylton N, Carp SA, Isakoff SJ, Mankoff D, Tromberg BJ, Yodh AG. PMID: 30338678; PMCID: PMC6194199.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    19. Orbital Metastases from Breast Cancer with BRCA2 Mutation: A Case Report and Literature Review. Case Rep Oncol. 2018 May-Aug; 11(2):360-364. Barber E, Lyou Y, Mehta R, Lin E, Lane K, Parajuli R. PMID: 29983698; PMCID: PMC6031950.
      View in: PubMed   Mentions: 1  
    20. Radiation-Associated Angiosarcoma of the Breast: A Case Report and Literature Review. Case Rep Oncol. 2018 Jan-Apr; 11(1):216-220. Lyou Y, Barber E, Mehta R, Lee T, Goreal W, Parajuli R. PMID: 29805371; PMCID: PMC5968252.
      View in: PubMed   Mentions: 6  
    21. Scaling of dentition and prey size in the California moray (Gymnothorax mordax). Zoology (Jena). 2017 06; 122:16-26. Harrison JS, Higgins BA, Mehta RS. PMID: 28236504.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    22. The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40. Ann Surg Oncol. 2017 Jul; 24(7):1853-1860. Bear HD, Tang G, Rastogi P, Geyer CE, Zoon CK, Kidwell KM, Robidoux A, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Paik S, Swain SM, Mamounas EP, Wolmark N. PMID: 27864694; PMCID: PMC5821429.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging. Cancer Res. 2016 10 15; 76(20):5933-5944. Tromberg BJ, Zhang Z, Leproux A, O'Sullivan TD, Cerussi AE, Carpenter PM, Mehta RS, Roblyer D, Yang W, Paulsen KD, Pogue BW, Jiang S, Kaufman PA, Yodh AG, Chung SH, Schnall M, Snyder BS, Hylton N, Boas DA, Carp SA, Isakoff SJ, Mankoff D, ACRIN 6691 investigators. PMID: 27527559; PMCID: PMC5148152.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    24. Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast. Oncologist. 2016 12; 21(12):1492-1494. Tran PN, Zhuang L, Nangia CI, Mehta RS. PMID: 27473043; PMCID: PMC5153352.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline. J Clin Oncol. 2016 09 01; 34(25):3069-103. Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN, Fallowfield L, Fowble B, Ingle JN, Jahanzeb M, Johnston SR, Korde LA, Khatcheressian JL, Mehta RS, Muss HB, Burstein HJ. PMID: 27217461.
      View in: PubMed   Mentions: 236     Fields:    Translation:Humans
    26. Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226. Br J Clin Pharmacol. 2016 06; 81(6):1134-41. Hertz DL, Barlow WE, Kidwell KM, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Livingston RB, Gralow J, Hayes DF, Hortobagyi GN, Mehta RS, Rae JM. PMID: 26859101; PMCID: PMC4876171.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. Lancet Oncol. 2015 Sep; 16(9):1037-1048. Bear HD, Tang G, Rastogi P, Geyer CE, Liu Q, Robidoux A, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Paik S, Swain SM, Mamounas EP, Wolmark N. PMID: 26272770; PMCID: PMC4624323.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    28. Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Transl Oncol. 2015 Jun; 8(3):204-9. Chen JH, Yu HJ, Hsu C, Mehta RS, Carpenter PM, Su MY. PMID: 26055178; PMCID: PMC4487259.
      View in: PubMed   Mentions: 26  
    29. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. Am Surg. 2014 Oct; 80(10):940-3. Bonev V, Evangelista M, Chen JH, Su MY, Lane K, Mehta R, Butler J, Hsiang D. PMID: 25264634; PMCID: PMC4343309.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    30. Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol. 2014 Feb; 109(2):158-67. Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen WP, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY. PMID: 24166728; PMCID: PMC4005994.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    31. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI. Magn Reson Imaging. 2013 Nov; 31(9):1465-71. Chen JH, Yu H, Lin M, Mehta RS, Su MY. PMID: 23992630; PMCID: PMC3795886.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    32. Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR. NMR Biomed. 2013 Dec; 26(12):1705-13. Chen JH, Pan WF, Kao J, Lu J, Chen LK, Kuo CC, Chang CK, Chen WP, McLaren CE, Bahri S, Mehta RS, Su MY. PMID: 23940080; PMCID: PMC3838444.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. A multi-locus molecular timescale for the origin and diversification of eels (Order: Anguilliformes). Mol Phylogenet Evol. 2013 Dec; 69(3):884-94. Santini F, Kong X, Sorenson L, Carnevale G, Mehta RS, Alfaro ME. PMID: 23831455.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    34. Combination anastrozole and fulvestrant in metastatic breast cancer. N Engl J Med. 2012 Aug 02; 367(5):435-44. Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN. PMID: 22853014; PMCID: PMC3951300.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCTClinical Trials
    35. Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy. Cancer Res. 2012 Sep 01; 72(17):4318-28. Ueda S, Roblyer D, Cerussi A, Durkin A, Leproux A, Santoro Y, Xu S, O'Sullivan TD, Hsiang D, Mehta R, Butler J, Tromberg BJ. PMID: 22777823; PMCID: PMC3609716.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    36. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr; 12(2):110-8. Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. PMID: 22444717; PMCID: PMC3342312.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    37. Bevacizumab added to neoadjuvant chemotherapy for breast cancer. N Engl J Med. 2012 Jan 26; 366(4):310-20. Bear HD, Tang G, Rastogi P, Geyer CE, Robidoux A, Atkins JN, Baez-Diaz L, Brufsky AM, Mehta RS, Fehrenbacher L, Young JA, Senecal FM, Gaur R, Margolese RG, Adams PT, Gross HM, Costantino JP, Swain SM, Mamounas EP, Wolmark N. PMID: 22276821; PMCID: PMC3401076.
      View in: PubMed   Mentions: 190     Fields:    Translation:Humans
    38. Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy. Philos Trans A Math Phys Eng Sci. 2011 Nov 28; 369(1955):4512-30. Cerussi AE, Tanamai VW, Hsiang D, Butler J, Mehta RS, Tromberg BJ. PMID: 22006904; PMCID: PMC3263790.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    39. Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys. 2011 Nov; 38(11):5961-8. Chang DH, Chen JH, Lin M, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang DJ, Nalcioglu O, Su MY. PMID: 22047360; PMCID: PMC3215688.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    40. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. PMID: 21878615; PMCID: PMC3219909.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    41. Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment. Proc Natl Acad Sci U S A. 2011 Aug 30; 108(35):14626-31. Roblyer D, Ueda S, Cerussi A, Tanamai W, Durkin A, Mehta R, Hsiang D, Butler JA, McLaren C, Chen WP, Tromberg B. PMID: 21852577; PMCID: PMC3167535.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    42. Spatial shrinkage/expansion patterns between breast density measured in two MRI scans evaluated by non-rigid registration. Phys Med Biol. 2011 Sep 21; 56(18):5865-75. Lin M, Chen JH, Mehta RS, Bahri S, Chan S, Nalcioglu O, Su MY. PMID: 21852724; PMCID: PMC3498815.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev. 2011 Feb; 20(2):389-96. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. PMID: 21217087; PMCID: PMC4110060.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    44. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? J Oncol. 2010; 2010. Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. PMID: 20885929; PMCID: PMC2946595.
      View in: PubMed   Mentions: 11  
    45. Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol. 2010 Aug; 17(8):1031-9. Cerussi AE, Tanamai VW, Mehta RS, Hsiang D, Butler J, Tromberg BJ. PMID: 20542448; PMCID: PMC2924201.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    46. Magnetic resonance imaging evaluation of noninflammatory breast cancer with skin involvement after neoadjuvant chemotherapy. Ann Surg Oncol. 2010 Jul; 17(7):1964-5. Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 20180030; PMCID: PMC2889290.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Continued Exploration of Bevacizumab in Breast Cancer. Ann Surg Oncol. 2010 Feb; 17(2):655-6. Mehta RS, Su MY. PMID: 19936837; PMCID: PMC2816792.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer. J Clin Oncol. 2009 Jun 20; 27(18):3067-8; author reply 3068-9. Mehta RS, Jackson D, Schubbert T. PMID: 19451417.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer. Anticancer Drugs. 2009 Apr; 20(4):301-4. Raj KP, Sanati H, Mehta RS, Zell JA. PMID: 19247177.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol. 2009 Jun; 16(6):1619-28. Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY. PMID: 19333654; PMCID: PMC2786305.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    51. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology. 2009 Jun; 251(3):653-62. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY. PMID: 19276320; PMCID: PMC2687529.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    52. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg. 2009 Mar; 249(3):448-54. Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY. PMID: 19247033; PMCID: PMC2789298.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    53. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res. 2009; 11(1):R9. Zell JA, Tsang WY, Taylor TH, Mehta RS, Anton-Culver H. PMID: 19228416; PMCID: PMC2687713.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    54. Rational and successful use of carboplatin and albumin-bound paclitaxel in a patient with recurrent metaplastic carcinoma who presented with multi-organ tumor emboli. Clin Breast Cancer. 2009 Feb; 9(1):56-9. Mehta RS, Schubbert T, Marshall J, Carpenter PM. PMID: 19299243.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox. J Clin Oncol. 2008 Jul 01; 26(19):3286-8; author reply 3288. Mehta RS. PMID: 18591566.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    56. Hormone receptor, grade, human epidermal growth factor receptor 2, and topoisomerase II as predictors of response to chemotherapy. J Clin Oncol. 2008 May 20; 26(15):2596; author reply 2596-7. Mehta RS. PMID: 18487578.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging. 2008 May; 27(5):1114-21. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY. PMID: 18425841; PMCID: PMC2613433.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    58. Re: HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials. J Natl Cancer Inst. 2008 May 07; 100(9):680; author reply 680-1. Mehta RS, Schubbert T. PMID: 18445822.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008 Jan 01; 112(1):17-26. Chen JH, Feig B, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. PMID: 18000804.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    60. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy. J Clin Oncol. 2007 Dec 10; 25(35):5667-9. Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. PMID: 18065744.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers. Ann Surg Oncol. 2008 Mar; 15(3):941-2. Chen JH, Agrawal G, Carpenter P, Mehta RS, Nalcioglu O, Su MY. PMID: 18004624.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy. Am Surg. 2007 Oct; 73(10):977-80. Yamamoto M, Mehta RS, Baick CH, Su MY, Lane KT, Butler JA, Hsiang DJ. PMID: 17983061.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging. 2007 Sep; 26(3):615-23. Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 17729334.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    64. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg. 2007 Sep; 142(9):855-61; discussion 860-1. Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, Butler JA. PMID: 17875840.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol. 2007 Jun 20; 25(18):2618-20. Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. PMID: 17577043.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A. 2007 Mar 06; 104(10):4014-9. Cerussi A, Hsiang D, Shah N, Mehta R, Durkin A, Butler J, Tromberg BJ. PMID: 17360469; PMCID: PMC1805697.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    67. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat. 2006 Aug; 5(4):401-10. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. PMID: 16866570.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    68. An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing. J Transl Med. 2006 Apr 24; 4:18. Wang K, Nishimoto KP, Mehta RS, Nelson EL. PMID: 16635268; PMCID: PMC1463012.
      View in: PubMed   Mentions: 4     Fields:    
    69. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res. 2005; 7(6):279-85. Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R. PMID: 16457705; PMCID: PMC1410753.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    70. Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat. 2005 Oct; 4(5):549-58. Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B. PMID: 16173825.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    71. Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma. Gynecol Oncol. 2005 Sep; 98(3):360-8. Tewari KS, Mehta RS, Burger RA, Yu IR, Kyshtoobayeva AS, Monk BJ, Manetta A, Berman ML, Disaia PJ, Fruehauf JP. PMID: 16000215.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    72. Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring. Technol Cancer Res Treat. 2002 Dec; 1(6):479-88. Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. PMID: 12625775.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    73. Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. Gynecol Oncol. 2002 Oct; 87(1):8-16. Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP. PMID: 12468336.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    Rita's Networks
    Concepts (209)
    Derived automatically from this person's publications.
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _